Preconception Multi for Women 60 capsules Batch 42469 recalled
NRC Nutrition Pty Ltd is recalling Preconception Multi for Women 60 capsules, Batch 42469, due to inconsistent blending of iodine in the product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA classified this as Class II. The source text does not report any illnesses or injuries and the hazard is inconsistent iodine blending in a dietary supplement, which represents a moderate labeling/quality control issue without reported adverse health consequences.
Plain-English summary
NRC Nutrition Pty Ltd is recalling Preconception Multi for Women 60 capsules in blister packs, Batch 42469, due to inconsistent blending of iodine in the product. The recalled product was distributed in Texas, Minnesota, California, Indiana, and Oklahoma.
Consumers who have purchased this product should stop using it and consult with their healthcare provider if they have any concerns.
The recalled product
- Product
- Preconception Multi for Women 60 capsules packaged in blister packs Batch 42469
- Manufacturer
- NRC Nutrition Pty Ltd
- Category
- Drug — Dietary Supplement
- Hazard
- iodine-inconsistency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch 42469
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateClinere Ear Wax Remover Recalled for Subpotent Carbamide Peroxide
FDA (Drugs) · 2026-07-22